Article info
Multiple sclerosis
Original research
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study
- Correspondence to Professor Francesco Patti, Department of Medical, Surgical Science and Advanced Technology "GF Ingrassia", University of Catania, Catania 95126, Italy; patti{at}unict.it
Citation
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study
Publication history
- Received November 21, 2019
- Revised March 16, 2020
- Accepted May 27, 2020
- First published July 13, 2020.
Online issue publication
August 14, 2020
Article Versions
- Previous version (13 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.